Campbell & CO Investment Adviser LLC Ascendis Pharma A/S Transaction History
Campbell & CO Investment Adviser LLC
- $1.3 Billion
- Q3 2024
A detailed history of Campbell & CO Investment Adviser LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 6,476 shares of ASND stock, worth $830,223. This represents 0.07% of its overall portfolio holdings.
Number of Shares
6,476
Previous 17,260
62.48%
Holding current value
$830,223
Previous $2.35 Million
58.9%
% of portfolio
0.07%
Previous 0.2%
Shares
5 transactions
Others Institutions Holding ASND
# of Institutions
241Shares Held
58.8MCall Options Held
250KPut Options Held
377K-
Ra Capital Management, L.P. Boston, MA9.71MShares$1.24 Billion20.22% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.13MShares$658 Million3.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.99MShares$640 Million11.21% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.41MShares$566 Million1.03% of portfolio
-
Janus Henderson Group PLC London, X04.19MShares$537 Million0.33% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.15B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...